Use of probiotics for the treatment of constipation in Parkinson's disease patients

Minerva Gastroenterologica e Dietologica

Volumn 57, Issue 2, 2011, Pages 117-121

  Cassani, E ^a   Privitera, G ^a   Pezzoli, G ^a   Pusani, C ^a   Madio, C ^a   Iorio, L ^a   Barichella, M ^a  

^a PARKINSON INSTITUTE   (Italy)

Author keywords

Constipation; Parkinson disease; Probiotics

Indexed keywords

LEVODOPA; PROBIOTIC AGENT;

ABDOMINAL PAIN; AGED; ARTICLE; BLOATING; CLINICAL ARTICLE; CONSTIPATION; DEFECATION HABIT; DRUG EFFICACY; FECES ANALYSIS; FEMALE; HIGH FIBER DIET; HUMAN; LACTOBACILLUS CASEI; MALE; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PILOT STUDY; TREATMENT DURATION;

AGED; CONSTIPATION; FEMALE; HUMANS; LACTOBACILLUS CASEI; MALE; PARKINSON DISEASE; PILOT PROJECTS; PROBIOTICS; TREATMENT OUTCOME;

EID: 79960641534     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chauduri KR, Naidu Y Early Parkinson disease and non motor issues. J Neur 2008;255:33-8.
2. Anderson G, Noorian AR, Taylor G, Anitha M, Bernhard D, Srinivasan S et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson disease. Exp Neurol 2007;207:4-12.
3. Zangaglia R, Martignoni E, Glorioso M , Ossola M, Riboldazzi G, Calandrella D et al. Macrogol for the treatment of constipation in Parkinson disease. Mov Disord 2007;22:1293-44.
4. Food and Agriculture Organization of the United Nations (FAO) 2001. Health and nutritional properties of probiotics in food including powder milk with live lacticacidbacteria [Internet]. Available from http://www.who.int/ foodsafety/publications/fs-management/en/probiotics.pdf [cited 2011, Apr 6).
5. Food and Agriculture Organization of the United Nations (FAO) 2002. Guidelines for the evaluation of probiotics in food [Internet]. Available from http://ftp.fao.org/es/esn/food/wgreport2.pdf [cited 2011, Apr 6].
6. Chmielewska A, Szajewska H. Systematic review of randomised controlled trials: probiotic for functional constipation. World J Gastroenterol 2010;16:69-75.
7. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni et al. The intestinal eco system in chronic functional constipation. Acta Paediatr. 1998;87:836-41. (Pubitemid 28409059)
8. Salminen S, Salminem E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol1997;222:45-8.
9. Rijkers GT, Bengmark S, Enck P, Haller D, Herz U, Kalliomaki M et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 2010;140:671S-6S.
10. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003;17:655-9. (Pubitemid 37536846)
11. Matsumoto K, Takada T, Shimizu K, Kado Y, Yamaoka Y, Hirano K et al. The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Bioscience Microflora 2006;25:39-48.
12. Yuki N, Watanabe K, Mike A, Tagami Y, Tanaka R, Ohwaki M et al. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies. Int J Food Microbiol 1999;48:51-7. (Pubitemid 29249296)
13. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 1998;52:899-907. (Pubitemid 29008371)
14. Tuohy KM, Pinart-Gilberga M, Jones M Hoyles L, McCartney AL, Gibson GR. Survivabdity of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J Appl Microbiol 2007;102:1026-32. (Pubitemid 46457479)
15. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improves the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 2001;57:S34-S38.
16. Romecriteria [Internet]. Available from http://www.romecriteria.org/pdfs/ constmode.pdf [cited 2011, Apr 6].
17. Kaye J, Gage H, Kimber A, Storey L, Trend P Excess burden of constipation in Parkinson's disease: a pilot study. Mov disord 2008;21:1270-3.
18. Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K et al. Dysautonomia rating scales in parkinson's disease: sialorrhea , dysphagia, and constipation - Critique and recommendations by movement disorders task force on rating scales for Parkinson disease. Mov Disord 2009;24:635-46.
19. De Preter V, Vanhoutte T, Huys G , Swings J, De Vuyst L, Rutgeerts P et al. Effects of LactobacUlus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 2007;292.G358-368.
20. Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol 2008;14:5020-4.